{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:23:35Z","timestamp":1787243015470,"version":"build-2736575974"},"reference-count":0,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Prevention of bronchopulmonary dysplasia (BPD) remains a critical unmet need.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We continued evaluating aerosolized vitamin A in a neonatal rat hyperoxia-injury model of BPD, testing whether lung-targeted inhalation yields superior outcomes compared to enteral or intramuscular (IM) delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Rat pups were exposed to continuous 95% hyperoxia for seven days to induce lung damage. Vitamin A was administered from post-natal day (PD) 1-7 by inhalation, enteral or IM dosing. Persisting effectiveness of inhaled vitamin A was examined at PD 21, dwelling in normoxia after all interventions were discontinued at PD 7.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Comprehensive analyses include alveolar morphometrics, in vivo pulmonary function testing, assessment of hepatic vitamin A level, and quantitating gene and protein expression of relevant biomarkers of lung maturation, inflammation and damage\/repair, employing singlex and multiplexed assays and whole-genome gene expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Inhaled vitamin A suppressed hyperoxia-induced lung damage, with key hallmarks of BPD, including lung morphometrics and biomarkers associated with lung damage and inflammation, being effectively indistinguishable from healthy controls at both PD 7 and 21, Natural reparative processes were enhanced, with normal alveolarization and pulmonary function at PD 21. Despite raising hepatic vitamin A levels, enteral dosing was ineffective in restoring alveolar morphology at PD 7. Consistent with previous reporting, IM dosing yielded modest effect at PD 7 but with little evidence of benefit to pulmonary function at PD 21. Observation of dose-dependent effects with aerosolized vitamin A strengthens the evidence of the benefits of lung-targeted delivery, supporting further development of inhaled vitamin A as a BPD preventive strategy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajrcmb\/aanag171","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:50:43Z","timestamp":1787226643000},"source":"Crossref","is-referenced-by-count":0,"title":["Inhaled vitamin A mitigates hyperoxia-induced acute and chronic lung damage in a neonatal rat model of bronchopulmonary dysplasia"],"prefix":"10.1093","author":[{"given":"Craig A","family":"Gelfand","sequence":"first","affiliation":[{"name":"Advent Therapeutics , 3805 Old Easton Road, Doylestown, Pennsylvania 18902"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Department of Pediatrics, , David Geffen School of Medicine at UCLA, 1124 W Carson Street, Torrance, California 90502"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Sakurai","sequence":"additional","affiliation":[{"name":"The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Department of Pediatrics, , David Geffen School of Medicine at UCLA, 1124 W Carson Street, Torrance, California 90502"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[{"name":"The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Department of Pediatrics, , David Geffen School of Medicine at UCLA, 1124 W Carson Street, Torrance, California 90502"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Yu","sequence":"additional","affiliation":[{"name":"The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Department of Pediatrics, , David Geffen School of Medicine at UCLA, 1124 W Carson Street, Torrance, California 90502"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gourav","family":"Chandan","sequence":"additional","affiliation":[{"name":"The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Department of Pediatrics, , David Geffen School of Medicine at UCLA, 1124 W Carson Street, Torrance, California 90502"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Madrigal","sequence":"additional","affiliation":[{"name":"The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Department of Pediatrics, , David Geffen School of Medicine at UCLA, 1124 W Carson Street, Torrance, California 90502"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisette","family":"Juan","sequence":"additional","affiliation":[{"name":"The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Department of Pediatrics, , David Geffen School of Medicine at UCLA, 1124 W Carson Street, Torrance, California 90502"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Segal","sequence":"additional","affiliation":[{"name":"Advent Therapeutics , 3805 Old Easton Road, Doylestown, Pennsylvania 18902"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virender K","family":"Rehan","sequence":"additional","affiliation":[{"name":"The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Department of Pediatrics, , David Geffen School of Medicine at UCLA, 1124 W Carson Street, Torrance, California 90502"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,20]]},"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/advance-article-pdf\/doi\/10.1093\/ajrcmb\/aanag171\/70724537\/aanag171.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/advance-article-pdf\/doi\/10.1093\/ajrcmb\/aanag171\/70724537\/aanag171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:25:52Z","timestamp":1787239552000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/advance-article\/doi\/10.1093\/ajrcmb\/aanag171\/8767160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1093\/ajrcmb\/aanag171","relation":{},"ISSN":["1535-4989"],"issn-type":[{"value":"1535-4989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"article-number":"aanag171"}}